great article, page-3

Following bit from the same article....

"We’ve had great news, much sooner than we expected. The first drug of our 2.5 chemistry, STAT-3, it’s a cancer drug. As it happened, in the Phase I study, we had two patients come into the study with end-stage diffuse B cell lymphomas. Both of these people were pre-hospice. They both failed 8, 10, 12 different chemotherapy regimens. And remarkably, both had prolonged and substantial partial responses. And that led to, what, five companies wanting to license the drug, and we ultimately decided to license it to Astra Zeneca."



How ANP is where it is is hard to digest!
GO ANP!!!